Point72 Hong Kong LTD Esperion Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $85,243 - $127,161	15,641 New	15,641 $105,000
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $7,907 - $19,596	-1,644 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $67,280 - $126,788	-5,933 Reduced 78.3%	1,644 $20,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $146,993 - $217,535	7,577 New	7,577 $160,000
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $37,052 - $54,412	-1,475 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $25,506 - $37,691	1,054 Added 250.36%	1,475 $38,000
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $103,767 - $175,418	-3,328 Reduced 88.77%	421 $16,000
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $112,619 - $192,361	3,749 New	3,749 $192,000
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $35,504 - $48,955	-1,030 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $13,192 - $17,216	-329 Reduced 24.21%	1,030 $48,000
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $54,509 - $72,801	1,359 New	1,359 $55,000
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $776 - $1,241	-21 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $855 - $1,079	21 New	21 $1,000
Q2 2018 Aug 14, 2018	SELL	$36.2 - $76.4 $24,036 - $50,729	-664 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $43,784 - $53,624	664 New	664 $48,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $171M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.